Aug 31 (Reuters) - Astivita Ltd (AIR) FY revenue from ordinary activities down 10.7 pct to $6.2 million FY total comprehensive expense $1 million versus expense $1.1 million
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status